Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses.

Dodd, Kimberly A; McElroy, Anita K; Jones, Megan E B; Nichol, Stuart T; Spiropoulou, Christina F

Dodd, Kimberly A; McElroy, Anita K; Jones, Megan E B; Nichol, Stuart T; Spiropoulou, Christina F.

Affiliation

Dodd KA; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

J Virol ; 87(11): 6161-71, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23536675

Subject(s)

Antibodies, Viral/immunology; Antibody Formation; CD4-Positive T-Lymphocytes/immunology; Nervous System Diseases/prevention & control; Rift Valley Fever/immunology; Rift Valley fever virus/immunology; Animals; B-Lymphocytes/immunology; CD8-Positive T-Lymphocytes/immunology; Female; Humans; Mice; Mice, Inbred C57BL; Nervous System Diseases/immunology; Nervous System Diseases/virology; Rift Valley Fever/virology; Viral Nonstructural Proteins/genetics; Viral Nonstructural Proteins/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Rift Valley Fever / Rift Valley fever virus / CD4-Positive T-Lymphocytes / Antibodies, Viral / Antibody Formation / Nervous System Diseases Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: J Virol Year: 2013 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google